Video

Daniel Albert, MD: Telemedicine for Rheumatic Care

How rheumatologists use telemedicine during COVID-19.

Telemedicine has been a boutique enterprise for the last dozen years, but recently, due to the coronavirus disease 2019 (COVID-19) pandemic, it has become front and center for many practitioners, including those focused on rheumatic care.

Daniel Albert, MD, of Dartmouth-Hitchcock, told HCPLive® in a recent interview that many providers and patients have had to do a quick ramp-up for the tools necessary to conduct such care and be cared for in such a way.

“It seems like it’s been very appealing to both groups and hopefully it will continue in largely the current format rather than the one that was unfortunately highly, highly regulated with a lot of barriers before COVID,” Albert said.

For Albert, he has an electronic health record (EHR) with a variant for his institution which permits a great deal of flexibility in terms of communication between patients and providers. The EHR allows for written documents, videos, still photos, and verbal and written interchange.

The platform that allows Albert to have a seamless video interaction with patients is called Vidyo. There are other variants that may have improved video or audio. A newer variant could allow for more devices being connected to the same interphase, and on Albert’s end, other students and staff members can be a part of the call to facilitate the conduct of the counter.

Providers are being careful to stay away from non-HIPAA compliant platforms like FaceTime and Skype.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.